IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma.

Kyle D KlingbeilJack Pengfei Tang Danielle S GrahamSerena Y LofftusAmit Kumar JaiswalTasha L LinChris FriasLucia Y ChenManando NakasakiSarah M DryJoseph G Crompton Fritz Christian EilberDinesh S RaoAnusha Kalbasi Brian E Kadera

Published in: Cancers (2023)

IGF2BP3 is highly expressed in a subset of WD/DD LPS. Across independent datasets, IGF2BP3 is also a biomarker of disease progression and worse survival.

Keyphrases

pi k akt
binding protein
growth hormone
inflammatory response
signaling pathway
anti inflammatory
rna seq